UTEK launches new online IP licensing platform for health-care devices

UTEK Corporation (NYSE Amex:UTK), a global IP licensing and innovation services company, is pleased to announce the launch of its new online IP licensing platform for health-care devices: www.MedicalDeviceLicensing.com. The site is the third for UTEK in the healthcare sector and represents an online global resource for open innovation, partnering, licensing and business development within the medical device industry.

The site’s unique services complement and enhance business development activity throughout the deal making process. The creation of a corporate Profile on the platform will unveil a company’s partnering requirements to a focused and targeted audience of the key decision-makers within the healthcare industry. In addition to the Profile Services, MedicalDeviceLicensing.com provides the Partner Search Service which analyzes the needs of a client, creating a “Prospect List” of pre-qualified potential partners, coordinating company introductions and handling deal negotiations.

Doug Schaedler, President of UTEK commented, “We are pleased to announce the addition of our newest online licensing platform. We feel that it will become a valuable tool in the medical device community and builds on the healthcare sector strength we currently have with the pharmalicensing.com site, already the leading licensing platform in the pharmaceutical sector.”  

http://www.utekcorp.com/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Enhancing the adoption of pragmatic clinical trial results in healthcare systems